Multimedia

May 18, 2017
References
  1. Grimes PE. Vitiligo: Management and prognosis. http://www.uptodate.com/home. Accessed Feb. 1, 2017.
  2. Lebwohl MG, et al. Vitiligo. In: Treatment of Skin Disease: Comprehensive Therapeutic Strategies. 4th ed. Philadelphia, Pa.: Elsevier; 2014. https://www.clinicalkey.com. Accessed Feb. 1, 2017.
  3. Felsten LM, et al. Vitiligo: A comprehensive overview. Journal of the American Academy of Dermatology. 2011;65:493.
  4. Whitton ME, et al. Interventions for vitiligo (review). Cochrane Database of Systematic Reviews. http://www.thecochranelibrary.com/view/0/index.html for link to abstract online. Accessed Feb. 1, 2017.
  5. Fleissig E, et al. Risk of sensorineural hearing loss in patients with vitiligo. Audiology and Neurotology. 2013;18:240.
  6. Craiglow BG, et al. Tofacitinib citrate for the treatment of vitiligo: A pathogenesis-directed therapy. JAMA Dermatology. 2015;151:1110.
  7. Ezzedine K, et al. Interventions for vitiligo. JAMA. 2016;316:1708.
  8. AskMayoExpert. Vitiligo. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2016.
  9. Vitiligo. American Academy of Dermatology. http://www.aad.org/dermatology-a-to-z/diseases-and-treatments/u---w/vitiligo. Accessed Feb. 1, 2017.
  10. Questions and answers about vitiligo. National Institute of Arthritis and Musculoskeletal and Skin Diseases. http://www.niams.nih.gov/Health_Info/Vitiligo/default.asp. Accessed Feb. 1, 2017.